Correlation Between Venus Concept and Vivos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Venus Concept and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Venus Concept and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Venus Concept and Vivos Therapeutics, you can compare the effects of market volatilities on Venus Concept and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Venus Concept with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Venus Concept and Vivos Therapeutics.

Diversification Opportunities for Venus Concept and Vivos Therapeutics

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Venus and Vivos is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Venus Concept and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Venus Concept is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Venus Concept are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Venus Concept i.e., Venus Concept and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Venus Concept and Vivos Therapeutics

Given the investment horizon of 90 days Venus Concept is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Venus Concept is 4.48 times less risky than Vivos Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,005  in Vivos Therapeutics on September 20, 2024 and sell it today you would lose (515.00) from holding Vivos Therapeutics or give up 51.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Venus Concept  vs.  Vivos Therapeutics

 Performance 
       Timeline  
Venus Concept 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Venus Concept has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Vivos Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Venus Concept and Vivos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Venus Concept and Vivos Therapeutics

The main advantage of trading using opposite Venus Concept and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Venus Concept position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.
The idea behind Venus Concept and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes